2Kaw LL Jr, Coimbra R, Potenza BM, et al. The use of recombinant factor VII for severe intractable bleeding during spine surgery. Spine ( Phila Pa 1976 ) , 2004,29 ( 12 ) : 1384-1387 ; discussion 1388.
5van den Berg H M, Fischer K. Prophylaxis for severe hemophilia: experience from Europe and the United States. Semin Thromb Hemost, 2003, 29:49-54.
6Mannucci P M. Hemophilia: treatment opinions in the twenty-first century. J Thromb Haemost. 2003. 1:1349-1355.
7Boggio L. Inhibitor development with second generation(sucrose formulated) recombinant factor Ⅷ. Biomed Prog, 2003, 16(Suppl 2):4--6.
8Lusher J M, Lee C A, Kessler C M, et al. The safety and efficacy of B-domain deleted recombinant factor Ⅷ concentrate in patients with severe haemophilia, Haemophilia, 2003, 9:38-49.
9Lethagen S. Desmopressin in mild Hemophilia A: indications, limitations, efficacy, and safety. Semin Thromb Hemost, 2003, 29 :101 - 106.
10Oranwiroon S, Akkarapatumwong V, Pung-Amritt P,et al. Determination of hemophilia A carrier by mutation analysis. Haemophilia, 2001, 7:20-25.
